Press Releases

Aug 11, 2009	ImaRx Therapeutics Reports Second Quarter Ended 2009 Financial Results
May 14, 2009	ImaRx Therapeutics Reports First Quarter Ended 2009 Financial Results
Mar 6, 2009	ImaRx Therapeutics Reports Fourth Quarter and Year Ended 2008 Financial Results
Nov 13, 2008	ImaRx Therapeutics Reports Third Quarter Ended 2008 Financial Results
Oct 17, 2008	ImaRx Therapeutics Receives NASDAQ Delisting Notification
Sep 24, 2008	ImaRx Therapeutics Divests Urokinase Franchise to Microbix Biosystems
Aug 26, 2008	ImaRx Therapeutics Receives Notification From NASDAQ Regarding Non-Compliance With NASDAQ's Stockholders' Equity, Market Value, or Net Income Requirements
Aug 14, 2008	ImaRx Therapeutics Reports Second Quarter Ended 2008 Financial Results
Nov 4, 2004	ImaRx's Clot Dissolving Technology Being Presented at the AHA Conference
Nov 1, 2004	ImaRx Top Scientist Granted Excellence in Biotechnology Award for Outstanding Achievement in Drug Delivery
Sep 28, 2004	ImaRx Commences SonoLysis Phase I/II Clinical Trials for Unique Vascular Blood Clot Treatment
Sep 9, 2004	ImaRx Presenting SonoLysis Technology at Two Major Conferences Using Microbubbles and Ultrasound to Dissolve Blood Clots